Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-03

Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia [NA]

View source ↗

Summary

Clinical trial update on the use of mitoxantrone hydrochloride liposome in combination with chemotherapy for untreated de novo acute myeloid leukemia. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acute Myeloid Leukemia | NA | Status: COMPLETED